“…In terms of fatality, only one case report described fatal outcome in a patient 3 weeks after the last ECT, who developed supraventricular tachycardia (32). Another report described development of Takotsubo cardiomyopathy few hours after the last ECT while on clozapine (24). Some of the recent studies have specifically assessed cognitive functions of patients receiving the combined treatment and One patient remained well for at least 6 weeks on clozapine after completion of ECT One patient remained weak with maintenance ECT and clozapine for 2 months Klapheke (15) Schizoaffective disorder, mania 1 Remained well for at least 3 weeks on clozapine after completion of ECT Safferman and Munne (54) Schizophrenia 1 Remained well for at least 3 weeks on clozapine after completion of ECT Factor et al (30) Psychosis related to Parkinson's disease Only one of the six patients became disturbed again after 6 months Kales et al (31) Schizophrenia (four of the five patients were clozapine-resistant) 5 Improvement sustained for less than 4 months in three of the five patients Long-term outcome -not good for most patients Chanpattana et al (52) Bipolar disorder, mania 1 Improved, maintained well for the 18-month period Kho et al (26) Schizophrenia (clozapine nonresponders) 11 During the mean follow-up duration of 16 (range 4-42) weeks, five patients had relapse of symptoms after the initial response.…”